UVB-Induced MVP Release in Human Skin
Completed · Phase 1
Conditions studied: Ultraviolet B Radiation, Microvesicle Particles
In brief
This study is designed to assess if ultraviolet B radiation (UVB) found in sunlight causes the release of microvesicle particles in human skin, and if antioxidant vitamins can block their production.
Key facts
- Study ID
- NCT05734235
- Run by
- Wright State University
- People needed
- 8
- Starts
- 2018-07-16
- Expected to finish
- 2022-10-26
- Last updated by the study team
- 2023-02-24
Who can join
Age: 21 and older, up to 45. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- Male subjects
- Ages 21 to 45
- Skin type: Fitzpatrick Type I or II
You may not qualify if…
- Have underlying diseases that could affect wound healing
- On medications that are known photosensitizers (e.g., doxycycline) or anti-inflammatories (e.g., NSAIDS [except for low-dose aspirin] or steroids)
- History of abnormal scarring (e.g., keloids)
- Should not be on Vitamin C or E supplements for past month
- Unable to understand/complete informed consent
- Large volar arm tattoos that would inhibit the ability to conduct/evaluate the skin testing
- Renal compromise/kidney stones or allergy to Vitamin C/Vitamin E or lidocaine anaesthetic
- Use of tanning bends or recent UVB exposure to the areas in the past 3 months
- Recent (within 1 week) use to sunscreen to volar forearms
Where it is running
- Wright State Physicians — Fairborn, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.